Can the keto diet be used to treat migraines?

In a recent study published in Frontiers in Nutrition, researchers investigate the potential protective effects of ketosis-inducing diets on migraines.

Study: Ketosis and migraine: a systematic review of the literature and meta-analysis. Image Credit: Chatham172 / Shutterstock.com Study: Ketosis and migraine: a systematic review of the literature and meta-analysis. Image Credit: Chatham172 / Shutterstock.com

Background

Headaches are widespread and a significant source of impairment globally. Current therapies for migraine prophylaxis lack specificity, have poor tolerability and limited efficacy, and have potential adverse effects, thus leading to poor results.

According to recent studies, certain dietary treatments may provide symptomatic relief from migraine episodes. The ketogenic diet, which substitutes glucose, the brain's primary source of energy, with ketone bodies, is a promising approach that may reduce the number or intensity of headaches.

About the study

In the present meta-analysis, researchers evaluate the efficacy of ketogenic dietary treatment (KDT) in migraine prevention and attenuation.

The ketogenic therapies tested in migraine treatments included the very-low-calorie ketogenic diet (VLCKD, four studies), modified Atkins diet (MAD, three studies), classic ketogenic diet (cKDT, two studies), and β-hydroxybutyrate administration (BHB). Ketogenic diets were characterized by high-fat, moderate-protein, and low-carbohydrate intake.

Data on the tolerability and efficacy of different ketogenic diets as compared to other control diets or placebos, as well as the levels of ketosis in migraine management among children, adolescents, and adults, were searched through the Cochrane Library, PubMed/Medline, Web of Science, Scopus, Science Direct, and LILACS databases.

Additional references from recent studies or those found in previous review articles were also included. Only observational studies and clinical trials published within the previous ten years in Italian, English, Spanish, or Portuguese were included.

Studies including individuals without migraine, assessing ketoses unrelated to ketogenic diets or exogenous ketone body administration, such as ketosis in diabetes, and outcomes unrelated to migraine episodes, were excluded from the analysis. Non-human studies with unavailable full text, opinion articles, reviews, letters, guidelines, comments, editorials, news, case reports, case series, abstracts, dissertations, theses, and animal or in vitro studies were also excluded.

Two researchers independently screened the data, with a third researcher resolving any disagreements between these two researchers. The Cochrane RoB version 2.0 tool was used to assess bias risks, whereas the Mixed Methods Appraisal Tool (MMAT) system evaluated evidence quality.

Study findings

Initially, 2,582 studies were identified, from which 169 duplicates were removed, and 2,413 were screened. Thereafter, 1,042 studies were excluded due to the wrong sample population, and 725 studies were removed due to out-of-data period.

Additionally, 215 studies were excluded due to the inclusion of other outcomes, 195 studies differed in publication type, 39 studies were excluded due to study design, 100 studies were conducted in animals, and 59 studies were published in a different language.

This led to 41 remaining studies, 12 of which were assessed for eligibility. A total of ten studies were ultimately considered for the final analysis after excluding three studies due to their publication type and one study due to the outcome evaluated.

Half of the studies had low bias risks, with most issues concerning randomization. All studies included only adult individuals.

Ketosis evaluation was inconsistent between the included studies, with a few studies evaluating ketonuria, some evaluating ketonemia, and others with no ketosis level evaluation. Thus, no relationships between ketosis levels and migraine prevention or reduced migraine episodes could be inferred.

Despite high levels of heterogeneity in the included studies, all ketogenic interventions showed significant effects, irrespective of exogenous or endogenous ketosis induction. A mean dropout rate of 21% was documented in the included studies and was higher among patients undergoing the classic ketogenic diet and lower for the modified Atkins diet at 34% and 13%, respectively.

Conclusions

The study findings indicate that ketogenic treatment may improve migraine treatment and should be studied further through randomized clinical trials with appropriate and standardized methodologies. Proper measurement of ketone levels during ketogenic therapy is essential to monitor adherence and improve understanding of the relationship between ketone bodies and efficacy.

Some important considerations include the correlation between migraine improvement and weight loss in overweight subjects, a lack of a well-defined association between blood and urine ketones, and potential mechanisms of action for ketogenic therapy. Future studies should evaluate compliance rates according to migraine type and diverse ketogenic dietary interventions, as well as their optimal duration, repeatability, feasibility in normal-weight individuals, and association with conventional migraine prophylaxis.

Journal reference:
  • de Cassya Lopes Neri, L., Ferraris, C., Catalano, G., et al. (2023) Ketosis and migraine: a systematic review of the literature and meta-analysis. Frontiers in Nutrition. doi:10.3389/fnut.2023.1204700
Pooja Toshniwal Paharia

Written by

Pooja Toshniwal Paharia

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Toshniwal Paharia, Pooja Toshniwal Paharia. (2023, July 02). Can the keto diet be used to treat migraines?. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20230702/Can-the-keto-diet-be-used-to-treat-migraines.aspx.

  • MLA

    Toshniwal Paharia, Pooja Toshniwal Paharia. "Can the keto diet be used to treat migraines?". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20230702/Can-the-keto-diet-be-used-to-treat-migraines.aspx>.

  • Chicago

    Toshniwal Paharia, Pooja Toshniwal Paharia. "Can the keto diet be used to treat migraines?". News-Medical. https://www.news-medical.net/news/20230702/Can-the-keto-diet-be-used-to-treat-migraines.aspx. (accessed November 21, 2024).

  • Harvard

    Toshniwal Paharia, Pooja Toshniwal Paharia. 2023. Can the keto diet be used to treat migraines?. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20230702/Can-the-keto-diet-be-used-to-treat-migraines.aspx.

Comments

  1. Beth Zupec-Kania Beth Zupec-Kania United States says:

    VLCKD stands for very low "carbohydrate" ketogenic diet, not "calories" as you wrote; there's a major difference.

    Beth Zupec-Kania, RDN, CD

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists discover how the keto diet may help some people with multiple sclerosis